About Cygenica Private Limited
Data last updated: 06 January 2026
Cygenica Private Limited is a private limited company based in Baleshwar, Orissa, India, a subsidiary of Cygenica Limited and recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 28 February 2017, the company has been in operation for over 9 years.
Registered with ROC Cuttack under CIN U74999OR2017PTC026637.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. Formerly known as Cyca Oncosolutions Private Limited. It is led by directors Saikh Fazlul Haque Krishnan and Nusrat Jahan Mobassarah Sanghamitra.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mobarakpur Soro Baleshwar, Orissa, India – 756045.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.43 Cr, a growth of 22% compared to the previous year.
It operates as a subsidiary of Cygenica Limited.
The company is associated with 1 brand - Cyca Oncosolutions.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cycaonco.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressMobarakpur Soro Baleshwar, Orissa, India – 756045
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Cygenica Private Limited
Cygenica Private Limited operates one associated brand: CyCa Oncosolutions. These brands represent Cygenica Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Proprietary drug delivery technology for cancer treatment is developed. | cycaonco.com |
Competitors & Alternatives of Cygenica Private Limited
Brands and companies operating in the same space as Cygenica Private Limited include Sutro Biopharma, Synthego, Avidity Biosciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Sutro Biopharma
|
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | United States | 2003 |
Synthego
|
CRISPR-engineered cell and gene therapies are developed for research applications. | Redwood City, United States, United States | 2012 |
Avidity Biosciences
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
Antheia
|
Yeast cells are genetically engineered to produce medicinal products. | Palo Alto, United States, United States | 2013 |
Vividion Therapeutics
|
Developing novel drugs based on a proteome-wide ligand and target discovery platform | Oceanside, United States, United States | 2016 |
Korro Bio
|
RNA-editing technologies are provided for precision medicine applications. | Cambridge, United States, United States | 2018 |
Straumann Group
|
Dental implants and regenerative dentistry products are developed. | Basel, Switzerland, Switzerland | 1954 |
Judges Scientific
|
Acquisition and development of scientific instrument businesses is conducted. | London, United Kingdom, United Kingdom | 2002 |
Savara Pharma
|
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | Austin, United States, United States | 2008 |
Univercells
|
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | Charleroi, Belgium, Belgium | 2013 |
Business Activity of Cygenica Private Limited
Cygenica Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | ********* |
Auditor Details of Cygenica Private Limited
Cygenica Private Limited is audited by Baheti & Somani LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Baheti & Somani LLP | blur-value | blur-value | blur-value |
Board of Directors of Cygenica Private Limited
Cygenica Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saikh Fazlul Haque Krishnan | Director | 28 Feb 2017 | 9 Years 4 Months | Current |
| Nusrat Jahan Mobassarah Sanghamitra | Managing Director | 28 Feb 2017 | 9 Years 4 Months | Current |
Financials of Cygenica Private Limited FY 2025 filings available
Cygenica Private Limited reported revenue of ₹1.43 Cr (up 22% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Cygenica Private Limited
As of FY 2023, Cygenica Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Cygenica Private Limited
Cygenica Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cygenica Private Limited
View historical data on people associated with Cygenica Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Cygenica Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Cygenica Private Limited
GSTIN & GST Filing Data of Cygenica Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Cygenica Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Cygenica Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Cygenica Private Limited
MSME Payment Delays by Cygenica Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Cygenica Private Limited
Subsidiaries & Group Companies of Cygenica Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Cygenica Private Limited with ownership details.
MCA Filings & Documents of Cygenica Private Limited
MCA Filings & Documents of Cygenica Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Cygenica Private Limited
Recent News on Cygenica Private Limited
Frequently Asked Questions about Cygenica Private Limited
Cygenica Private Limited is an active private limited company in the life sciences sector based in Baleshwar, Orissa, India. It was incorporated on 28 February 2017 (9+ years old) and is registered under CIN U74999OR2017PTC026637.
Cygenica Private Limited reported revenue of ₹1.43 Cr for FY 2025 (up 22.00% YoY).
The current directors of Cygenica Private Limited are:
The primary industry of Cygenica Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes, Cygenica Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Cygenica Private Limited can be reached at the registered office: Mobarakpur Soro Baleshwar, Orissa, India – 756045, or through the website cycaonco.com.